
Genetic Vectors Inc Profile last edited on: 2/8/19
CAGE:
UEI:
Business Identifier: Nucleic acid labeling and detection technology Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 25
County: Miami-Dade
Congr. District: 25
County: Miami-Dade
Public Profile
Genetic Vectors, Inc. (OTC: GVEC) was a biotechnology company developing diagnostic and quality control tools for the biotechnology and molecular biology markets. The technology intended to allow biopharmaceutical companies in monitoring the purity. The company owned proprietary rights over the EpiDNA technology for the labeling and detection of nucleic acids, particularly in DNA. The technology was the basis for the company's product line EpiDNA, the Picogram assay and EasyID - technology utilized for the detection of yeasts in the food and beverage and the brewing and wine making industry. The company acquired DNA Sciences, Inc. during January 2000 but was delisted shortly therafter. In October 2001, complet inventory of the firm was auctioned off.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
5-9Revenue Range
.5M-1MVC funded?
YesPublic/Private
Publicly TradedStock Info
OTC : GVECIP Holdings
1-4Awards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2000 | 1 | NIH | $100,000 | |
Project Title: Novel RNASE Protection Assay For Cytokine MRNAS | ||||
1997 | 1 | NIH | $99,897 | |
Project Title: Rapid Identification Of Fungal Species | ||||
1993 | 1 | NIH | $49,998 | |
Project Title: Non radioactive nucleic acid labeling technology |
Key People / Management
Mead M McCabe -- President
Company News
There are no news available.